cd279

navigate by keyword : programmed cell death pd1 surface receptor immune white blood system apoptosis inhibitor tumor cancer pdl1 ligand nivolumab antibody melanoma metastatic pembrolizumab cd274 listeria pdb3bik immunotherapy cd279 pdcd1 checkpoint structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model rendering illustration cartoon transparent semitransparent blue pink stylized gradient glow black background

Programmed cell death 1 (PD-1, CD279, blue) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, red) protein, 3D Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279, blue sheets) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, green Royalty Free Stock Photo

Programmed cell death 1 PD-1, CD279 receptor protein. PD-1 is a major cancer drug target. 3D rendering, beads on a string. Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279) receptor protein, 3D rendering. PD-1 is a major cancer drug target. Atoms are represented as Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279, blue) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, green) protein,

Programmed cell death 1 (PD-1, CD279) receptor protein, 3D rendering. PD-1 is a major cancer drug target. Cartoon representation Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279) receptor protein. PD-1 is a major cancer drug target. 3D rendering based on protein data Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279) immune checkpoint protein Royalty Free Stock Photo

Programmed cell death 1 (PD-1, CD279, blue) immune checkpoint protein bound to programmed death-ligand 1 (PD-L1, green) protein, 3D rendering. PD-L1 is produced by tumors to suppress the immune system. Blockers of the PD-L1 and PD-1 interaction are an important new anticancer drug class and include nivolumab and pembrolizumab. 3D rendering based on protein data bank entry 3bik. Stylized